How Do You Get Influenza A: Causes and Spread

Influenza A spreads through droplets, surfaces, and air. Learn how the virus enters your body, when people are most contagious, and how to lower your risk.

Influenza A spreads primarily through virus-laden particles released when an infected person breathes, talks, coughs, or sneezes. These particles range from large droplets that settle quickly to tiny aerosols that hang in the air, and both can deliver the virus to your respiratory tract. Contact with contaminated surfaces plays a smaller role, but the virus can also enter through a less obvious route: your eyes. The story of how influenza A reaches you involves the virus itself, the air between you and a sick person, the surfaces you touch, and even the weather outside.

Airborne Particles Are the Main Vehicle

Influenza A travels between people through three routes: contact (direct or via contaminated objects), large respiratory droplets, and fine aerosol particles. For decades, researchers debated which route matters most. A study examining transmission in a ferret model found that airborne spread was efficient compared with spread through contaminated surfaces, giving strong experimental evidence that the air is the dominant pathway. Research in human volunteers and healthcare settings backs this up, with volunteer studies suggesting that infections acquired through aerosols may carry a higher risk of developing fever and more serious illness than those picked up by other routes.

The practical difference between droplets and aerosols matters for everyday life. Large droplets are heavy enough to fall to the ground within a meter or two, so standing at arm’s length from a coughing person reduces your exposure. Aerosols, on the other hand, are tiny enough to stay suspended in a room for minutes to hours, especially in poorly ventilated spaces. That is why crowded, stuffy indoor environments are such reliable breeding grounds for flu transmission.

Surfaces and Hands Still Play a Role

Though the air gets most of the blame, contaminated surfaces are not irrelevant. Influenza A survives on hard, nonporous surfaces like stainless steel and plastic for 24 to 48 hours, while on softer materials like cloth and paper it lasts less than 8 to 12 hours. The virus can transfer from stainless steel to your hands for up to 24 hours after contamination, and once on your hands, it remains viable for about five minutes. Five minutes may not sound like much, but it is more than enough time to rub your nose or eyes.

This is the sequence that makes fomite transmission work: a sick person coughs into their hand, touches a doorknob, you grab the same doorknob, and then you touch your face. Each link in that chain has to hold for you to get infected, which is why surface transmission is thought to be less efficient than breathing in aerosols directly. Still, during heavy environmental contamination, like in a household with a sick family member or a hospital ward, the cumulative opportunity for surface-to-hand-to-face transfer adds up.

Your Eyes Are a Less Obvious Entry Point

Most people think of the flu as entering through the nose and mouth, but both human and avian influenza A viruses can use the eye as a portal of entry. In ferret experiments, influenza A viruses delivered to the eyes produced respiratory infections just as readily as viruses delivered through the nose, with peak viral loads and aerosol shedding that were essentially identical between the two routes. The virus lands on the conjunctiva, the thin membrane covering the eye and inner eyelid, and from there can travel to the upper respiratory tract to establish a full-blown infection.

This is why rubbing your eyes with unwashed hands is not just an abstract hygiene warning. If your fingers picked up the virus from a surface or from touching your own mask, the eyes offer a direct path for the virus to establish itself. People who wear contact lenses or work in environments where splashes are possible, like healthcare or food service, may want to keep this route in mind.

How the Virus Gets Inside Your Cells

Once influenza A particles land on the lining of your respiratory tract or eye surface, the virus needs to physically latch onto your cells to get inside. It does this through a protein on its surface called hemagglutinin, which binds to sialic acid molecules found on the surface of human cells. Human influenza A viruses have evolved to prefer a specific type of sialic acid linkage found in the human upper airway. That binding triggers the cell to pull the virus inside through a normal process called endocytosis, where the cell membrane wraps around the virus particle and absorbs it.

Your airway lining is not defenseless, though. The mucociliary clearance system, a carpet of mucus-producing and hair-like ciliated cells, actively sweeps foreign material out of your respiratory tract. Early in an influenza A infection, the virus actually triggers an increase in ciliary activity, essentially speeding up the conveyor belt to try to flush the virus out before it can take hold. Whether you get infected depends partly on how much virus you inhaled and partly on whether this initial defense can clear it fast enough.

The Timeline From Exposure to Contagiousness

If enough virus gets past your defenses, the clock starts ticking. Modeling of H1N1 infection dynamics in human volunteers found that the latent period, the gap between exposure and becoming infectious yourself, ranged from about 0.7 to 1.9 days. In the same study, infectiousness lasted anywhere from about one to seven days, with people who developed systemic symptoms like fever and body aches shedding roughly 15 times more virus than those without such symptoms.

People who never develop symptoms still contribute to transmission, though to a lesser degree. A household transmission study estimated that about 36% of influenza cases were asymptomatic, and these asymptomatic cases were roughly 57% as infectious as symptomatic ones. That makes the flu harder to contain than diseases where you only spread it once you feel sick. You can be passing influenza A to your coworkers or family members before you have any reason to stay home.

Why Winter Is Flu Season

Influenza A follows a predictable seasonal pattern in temperate climates, peaking in winter months. This is not coincidence or folklore. Experimental work in guinea pigs demonstrated that influenza virus transmission is strongly affected by both temperature and humidity, and epidemiological studies have confirmed robust links between influenza rates and local weather conditions in temperate regions.

Cold, dry air helps the virus in at least two ways. First, low humidity lets respiratory droplets evaporate faster, shrinking them into lighter aerosol particles that travel farther and linger longer. Second, cold air dries out the mucous membranes in your nose and throat, weakening that first-line defense. Add in the behavioral side, people spending more time indoors in close quarters with recirculated air, and you have a recipe for rapid spread. In tropical regions, the pattern is different and less well understood, with flu activity sometimes peaking during rainy seasons when people also congregate indoors.

Ventilation Changes the Math

Because aerosols are such an important route, how much fresh air flows through a room directly affects your risk. A scoping review of ventilation measures in schools found that improving ventilation consistently lowered airborne infection risk. A study in a large teaching hospital found that infection risk dropped rapidly with increasing outdoor air exchange, with the risk from a 45-minute exposure to influenza falling to about 3.6% in a room with a relatively high air exchange rate.

Shared bedrooms are a particularly risky environment. A simulation study of children sharing a bedroom found that respiratory viral infection risks can be high, especially with low fresh air ventilation and furniture arranged so that exhaled air plumes form between the faces of the two sleepers. Increasing the air exchange rate disrupted these plumes and lowered risk. The implication for households where one person is sick is straightforward: open a window, run a fan, and if possible, do not share a bedroom during the most infectious days.

Where New Strains Come From

Wild aquatic birds, particularly dabbling ducks like mallards, are the natural reservoir for influenza A viruses and carry a broad range of viral subtypes. In birds, the virus typically targets a different type of sialic acid receptor than the one preferred by human-adapted strains. Pigs, however, carry both the bird-type and the human-type receptor on their airway cells, which is why they have long been considered a “mixing vessel” where bird and human influenza viruses can swap genetic segments.

This genetic mixing, called reassortment, is one of the two major ways influenza A reinvents itself. When two different influenza A subtypes infect the same cell in a pig (or occasionally in a person or bird), their gene segments can shuffle and produce a new combination the human immune system has never encountered. This is antigenic shift, and it is the mechanism behind pandemics. The more routine process is antigenic drift: small mutations accumulate in the virus’s surface proteins over time, gradually making the current season’s virus different enough from last year’s version that your immune system does not fully recognize it. Drift is why the flu comes back every year; shift is why, on rare occasions, it comes back as something much worse.

Why Some People Get Hit Harder

Not everyone exposed to influenza A gets equally sick, and genetics plays a part. A polymorphism in a gene called IFITM3 has been shown to influence the severity of influenza infection, particularly in Asian populations, where one variant is more common. IFITM3 produces a protein that normally helps block viruses from entering cells, so people with a less effective version of the gene may be at greater risk of severe illness if they catch the flu.

Your immunological history matters too. The first influenza virus you encounter in childhood creates a lasting imprint on your immune system, shaping how you respond to future strains. This phenomenon, sometimes called “original antigenic sin,” means your body preferentially recalls antibodies from that initial infection even when facing a different subtype years later. Ferret experiments and human studies have confirmed that these early imprints influence the types of antibodies you produce against later infections, which can leave gaps in your protection against subtypes your childhood immune system never saw. This partly explains why different age groups are hit differently in each flu season: the dominant strains align better or worse with the immunological memories of people born in different decades.

What Vaccination Actually Does and Does Not Prevent

Flu vaccination is the single most recommended measure for preventing influenza A, but its effects on transmission deserve a closer look than “get your shot and you’re safe.” In terms of preventing household spread, a study of secondary infections among vaccinated household contacts estimated overall vaccine effectiveness at about 21%, with the protection against influenza A specifically coming in at a modest 5%, compared to a more impressive 56% against influenza B. Those numbers highlight an honest limitation: flu vaccines are better at reducing how sick you get than at completely blocking infection.

And the evidence for reduced severity is real. Among vaccinated outpatients who still caught the flu, one study found about 9% fewer reported symptoms compared to unvaccinated patients. Among hospitalized older adults, vaccination was associated with a 64% reduction in the odds of dying in the hospital from influenza. So while the vaccine may not reliably stop you from catching influenza A, it can meaningfully lower the chance that you end up in serious trouble.

Masks, Air, and the Rest of the Prevention Toolkit

Masks have been a lightning rod for debate, and the evidence is more nuanced than partisans on either side tend to admit. A large randomized trial comparing N95 respirators to standard medical masks among healthcare workers found no significant difference in laboratory-confirmed influenza rates between the two groups as they were actually worn in outpatient settings. That does not mean masks are useless. Modeling work has shown that population-wide mask use could make a meaningful contribution to slowing an influenza pandemic by reducing the reproduction number, the average number of people each sick person infects. The gap between those findings reflects a real tension: masks filter particles, but their real-world benefit depends heavily on how consistently and correctly people wear them, and on whether they are combined with other measures.

Vaccination of healthcare workers represents another layer of protection worth mentioning, since it reduces transmission from staff to vulnerable patients in hospitals and clinics. Beyond individual behavior, institutional decisions about ventilation matter just as much. Keeping fresh-air exchange rates high in workplaces, schools, and healthcare facilities lowers the concentration of virus-laden aerosols in shared spaces, reducing everyone’s dose exposure at once. Of all the environmental interventions, improving the air people breathe together may be the most underappreciated tool for cutting influenza A transmission.

Shared Spaces and Dose

Whether you actually get infected after exposure depends in part on the dose of virus you inhale. A quick pass through an airport terminal exposes you to a different viral load than eight hours in a cramped office with a coughing coworker. The relationship between dose and infection probability is roughly linear at low doses, meaning that even partial reductions in exposure, from a mask, an open window, or simply spending less time in a contaminated room, translate into a proportional reduction in your risk. This is one of the most useful pieces of information for everyday decision-making: you do not need to eliminate all exposure to meaningfully lower your odds of getting the flu. Every small barrier between you and virus-laden air counts, even imperfect ones.

Households illustrate this well. When a family member comes home sick, the shared kitchen and bathroom create repeated low-level exposures, and if the sick person is symptomatic they are shedding far more virus than someone with a silent infection. In hospital settings, modeling suggests that giving antiviral prophylaxis to exposed patients and reducing shared-room occupancy are among the most effective measures for limiting nosocomial spread. The lesson generalizes beyond hospitals: fewer people per room, fresher air, and prompt treatment of the sick person all shrink the viral dose that everyone else breathes in.